Abstract
Neuroinflammation, a major pathological factor contributing to various neurodegenerative diseases, is closely associated with gut microbiota imbalance. The aim of this study was to establish a rapid and efficient screening method to obtain potential anti-neuroinflammatory strains. Firstly, 94 strains isolated from different sources were screened against neuroinflammation in lipopolysaccharide (LPS)-activated BV-2 cells model to identify potential strains quickly. In vitro cellular experiments revealed that 21 strains significantly inhibited nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) activity, which were selected for further evaluation of gastrointestinal tolerance and adhesion properties. Among them, 18 strains with promising probiotic properties were further confirmed for anti-neuroinflammatory effects in vivo using the CuSO4-induced zebrafish model. The results showed that eight strains significantly mitigated the migratory behavior of zebrafish neutrophils and the mRNA expression level of pro-inflammatory cytokines IL-1β compared to other strains. Additionally, Lactiplantibacillus plantarum and Limosilactobacillus fermentum were identified as the main species by sequencing their 16S rDNA. In conclusion, this cell-zebrafish model is promising for high-throughput screening of novel probiotics with potential anti-neuroinflammation activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
